# eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial (eBRAVE-AF)

> **NCT04250220** · NA · UNKNOWN · sponsor: **LMU Klinikum** · enrollment: 4400 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DIAGNOSTIC_TEST:** e-Health based strategy: PPG-based screening using a smartphone and ECG patch

## Key facts

- **NCT ID:** NCT04250220
- **Lead sponsor:** LMU Klinikum
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-03
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 4400 (ESTIMATED)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04250220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04250220, "eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial (eBRAVE-AF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04250220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*